London, United Kingdom

Ming Yuan

This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: University of London. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Yuan. Retrieved from https://idiyas.com/inventor/ming-yuan-ekihxswt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ming Yuan

Introduction

Ming Yuan is a prominent inventor based in London, GB. He has made significant strides in the field of cancer treatment through his innovative research and development. His work focuses on utilizing modified viruses to combat cancer, showcasing his commitment to advancing medical science.

Latest Patents

Ming Yuan holds a patent for an "Oncolytic Vaccinia Virus With Modified B5R Gene For The Treatment Of Cancer." This groundbreaking invention represents a novel approach to cancer therapy, potentially offering new hope for patients battling this disease. His patent portfolio includes 1 patent, reflecting his focused contributions to the field.

Career Highlights

Ming Yuan is affiliated with the University of London, where he conducts his research and collaborates with other experts in the field. His academic background and ongoing research efforts position him as a key player in the development of innovative cancer treatments.

Collaborations

Ming Yuan has worked alongside notable colleagues, including Yaohe Wang and Robert Nicholas Lemoine. These collaborations enhance the depth and breadth of his research, fostering an environment of innovation and discovery.

Conclusion

Ming Yuan's contributions to cancer treatment through his patented research exemplify the impact of innovation in medicine. His work not only advances scientific understanding but also holds the potential to improve patient outcomes in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…